Cancer is one of the main problems in public health worldwide. Despite rapid advances in the diagnosis and treatment of cancer, the efficacy of current treatment strategies is still limited. There are promising new results in animal models whereby mesenchymal stem cells (MSCs) can be used as vehicles for targeted therapies. The use of MSCs as therapeutic biological vehicles in cell therapy has several advantages, including immune-silence, tumor tropism, easy and rapid isolation, ex vivo expansion, multilineage differentiation and the capacity to deliver a number of therapeutic agents. Some studies have shown that the microenvironment of the tumor provides a preferential niche for homing and survival of MSCs. Here, we have highlighted various applications of MSCs in cancer gene therapy.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Mirzaei H, Sahebkar A, Avan A, Jaafari M, Salehi R, Salehi H et al. Application of mesenchymal stem cells in melanoma: a potential therapeutic strategy for delivery of targeted agents. Curr Med Chem 2015; 23: 455–463.
Loebinger MR, Janes SM . Stem cells as vectors for antitumour therapy. Thorax 2010; 65: 362–369.
Bao Q, Zhao Y, Niess H, Conrad C, Schwarz B, Jauch K-W et al. Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells Dev 2012; 21: 2355–2363.
Dwyer RM, Khan S, Barry FP, O’Brien T, Kerin MJ . Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res Ther 2010; 1: 25.
Kolluri KK, Laurent GJ, Janes SM . Mesenchymal stem cells as vectors for lung cancer therapy. Respiration 2013; 85: 443–451.
Ren C, Kumar S, Chanda D, Kallman L, Chen J, Mountz JD et al. Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model. Gene Ther 2008; 15: 1446–1453.
Choi SH, Tamura K, Khajuria RK, Bhere D, Nesterenko I, Lawler J et al. Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas. Mol Ther 2015; 23: 235–243.
Stuckey DW, Hingtgen SD, Karakas N, Rich BE, Shah K . Engineering toxin‐resistant therapeutic stem cells to treat brain tumors. Stem Cells 2015; 33: 589–600.
Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155–1164.
Duan X, Guan H, Cao Y, Kleinerman ES . Murine bone marrow–derived mesenchymal stem cells as vehicles for interleukin‐12 gene delivery into Ewing sarcoma tumors. Cancer 2009; 115: 13–22.
The authors declare no conflict of interest.
About this article
Cite this article
Mohammadi, M., Jaafari, M., Mirzaei, H. et al. Mesenchymal stem cell: a new horizon in cancer gene therapy. Cancer Gene Ther 23, 285–286 (2016). https://doi.org/10.1038/cgt.2016.35
Cancer Cell International (2020)
Cell & Bioscience (2020)
Cell Communication and Signaling (2020)
Journal of Ovarian Research (2020)
The safety of a therapeutic product composed of a combination of stem cell released molecules from adipose mesenchymal stem cells and fibroblasts
Future Science OA (2020)